Stay tuned and follow the latest
developments and news in Molecular Oncology.

Genekor Medical is pleased to announce its participation in the ASCO Annual Meeting 2026, taking place on May 29 – June 2, 2026, in Chicago, Illinois, with four scientific online […]
Read More
Genekor Medical was proud to take part in Vilnius Breast Meeting 2026, held on 8–9 May 2026 in Vilnius. The congress brought together an outstanding international community of specialists, including […]
Read More
Genekor Medical actively participated in the 8th Hellenic Society of Medical Oncology (HeSMO) Congress, held on May 6–9 at the Makedonia Palace in Thessaloniki, contributing to the scientific discussions shaping […]
Read More
Genekor Medical participated in ESMO Breast 2026 in Berlin, one of the most important international congresses dedicated to breast cancer. As part of the congress, the scientific team of Genekor […]
Read More
Athens, March 12, 2026 Genekor Medical continues to strengthen its active role in corporate social responsibility, supporting once again the organization “The Smile of the Child”, and contributing meaningfully to […]
Read More
Genekor participated in the San Antonio Breast Cancer Symposium (#SABCS), held on December 9–12, 2025 in Texas, one of the leading international scientific congresses dedicated to breast cancer research and clinical management. During […]
Read More
ADEA Lab, a diagnostic laboratory specialized in precision medicine, and Genekor Medical S.A., a leader in molecular diagnostics, are pleased to announce a strategic alliance focused on delivering cutting-edge precision […]
Read More
Genekor attended the 11th Hellenic Congress of the Breast Surgery (EXEM), held in Athens from 14 to 16 November 2025 at the Royal Olympic Hotel, contributing to the scientific dialogue on current developments in breast […]
Read More
Genekor Medical S.A., in collaboration with Women for Oncology – W4O Hellas, announces its participation in the initiative “Genetic Testing for Breast Cancer” (Participation Code: GEN-BC25). As part of this initiative, up […]
Read More